Abstract: The present invention provides a windshield that has a display region onto which information is projected using light emitted from a head-up display device, the windshield including an outer glass plate, an inner glass plate that is arranged opposite to the outer glass plate, and an interlayer that is arranged between the outer glass plate and the inner glass plate, wherein lattice points are defined at a pitch of no greater than 20 mm in the display region, and when wedge angles at the lattice points are measured using an interferometer with 240×240 pixels or more, a difference between the largest value and the smallest value of the wedge angles is no greater than 0.32 mrad.

Abstract: An optical observation device for observing a target located at a distant observation sight that comprises an observation telescope and an infrared sighting device. The infrared sighting device eventually provides a visual target image as a sighting marker from a thermal infrared image of the observation sight. The sighting marker and the observation sight are simultaneously viewed in the field of view of the observation telescope so as to enable training of the observation telescope on a part of the observation sight where the target is located.

Abstract: An optical observation device for observing a target located at a distant observation sight that comprises an observation telescope and an infrared sighting device. The infrared sighting device eventually provides a visual target image as a sighting marker from a thermal infrared image of the observation sight. The sighting marker and the observation sight are simultaneously viewed in the field of view of the observation telescope so as to enable training of the observation telescope on a part of the observation sight where the target is located.

Abstract: An image stabilizer applicable to a monocular or binocular optical system. The stabilizer includes an erecting prism placed between an objective lens and an eyepiece to compensate for deterioration in a quality of an observed image caused by hands movement. The image stabilizer includes a gimbal suspension system having pivot shafts respectively extending to left and right sides of the optical axis of the optical system. The pivot shafts have a common pivot axis perpendicular to the optical axis. The gimbal suspension system has an erecting-prism holder supported by the pivot shafts, an angular velocity detector for detecting an angular displacement of the erecting prism, and a voice coil motor for pivoting the erecting-prism holder.

Abstract: An image stabilizing device and system for a binocular telescope having a pair of telescopic optical systems each comprising an objective lens, a gimbal mounted erecting prism and an eyepiece lens which is capable of compensating for deterioration in quality of an observed image due to user hand shake or other external vibrations.

Abstract: An optical image stabilizer for a telescopic instrument having an objective lens, an erect prism, and an eyepiece lens arranged in this order which is capable of compensating for image deteriorations of an observed image due to external vibrations. The optical image stabilizer has a gimbal device mounted on a telescope housing, an external gimbal frame rotatably mounted on the gimbal casing, and an internal gimbal frame with the erect prism fixed thereto. Voice coil motors are provided for rotating the external and the internal gimbal frames. One of the voice coil motors has a coil disposed on the circuit board and a permanent magnet disposed on either one of the external and the internal gimbal frames oppositely to the coil. The remaining voice coil motor has a coil disposed on the circuit board and a permanent magnet disposed on the other gimbal frame oppositely to the coil.

Abstract: An image stabilizing device and system for a binocular telescope having a pair of telescopic optical systems each comprising an objective lens, a gimbal mounted erecting prism and an eyepiece lens which is capable of compensating for deterioration in quality of an observed image due to user hand shake or other external vibrations.

Abstract: An optical image stabilizer for a telescopic instrument having an objective lens, an erect prism, and an eyepiece lens arranged in this order which is capable of compensating for image deteriorations of an observed image due to external vibrations. The optical image stabilizer has a gimbal device mounted on a telescope housing, an external gimbal frame rotatably mounted on the gimbal casing, and an internal gimbal frame with the erect prism fixed thereto. Voice coil motors are provided for rotating the external and the internal gimbal frames. One of the voice coil motors has a coil disposed on the circuit board and a permanent magnet disposed on either one of the external and the internal gimbal frames oppositely to the coil. The remaining voice coil motor has a coil disposed on the circuit board and a permanent magnet disposed on the other gimbal frame oppositely to the coil.

Abstract: An image stabilizer applicable to a monocular or binocular optical system. The stabilizer includes an erecting prism placed between an objective lens and an eyepiece to compensate for deterioration in a quality of an observed image caused by hands movement. The image stabilizer includes a gimbal suspension system having pivot shafts respectively extending to left and right sides of the optical axis of the optical system. The pivot shafts have a common pivot axis perpendicular to the optical axis. The gimbal suspension system has an erecting-prism holder supported by the pivot shafts, an angular velocity detector for detecting an angular displacement of the erecting prism, and a voice coil motor for pivoting the erecting-prism holder.

Abstract: The object of this invention is to provide a novel pharmaceutical composition for getting rid of pains and anxiety in patients. This invention relates to a pharmaceutical composition containing lactoferrin as an active ingredient. The composition of this invention is useful for treatment of at least one disease or condition selected from the group consisting of pains, including the phase 1 pain and the phase 2 pain, anxiety and stress. The composition is particularly beneficial to alleviating or getting rid of the pain and anxiety which significantly lower quality of life of patients with end-stage cancer. The composition of this invention is also useful for treatment of pains, including the phase 1 pain and the phase 2 pain, and inflammation which accompany arthritis or diseases in the junctions of bones (e.g. rheumatoid arthritis, osteoarthritis, frozen shoulder, sports injuries such as tennis elbow and baseball shoulder, and low back pain).

Abstract: A light source device for a fiber optic illumination system comprises a solid-state light emitting element having an emission surface shaped in quadrate, a light collection lens system with a positive power comprising at least a plano-convex lens, and a reflection member having a cylindrical reflection surface therein, all of which are arranged in this order coaxially with one another along a principal axis passing a center of the light emitting element, wherein the plano-convex lens is placed with a plane surface thereof directly facing and located at a space distance apart from the emission surface so as to form a virtual image of the emission surface.

Abstract: Ascochlorin or an analog or derivative thereof and a compound having a primary amino group are mixed and reacted with each other in the presence/absence of a basic catalyst to synthesize a novel imino compound. The novel imino compound thus synthesized is a ligand capable of activating nuclear receptor superfamily such as retinoid orphan receptor (RXR), peroxisome proliferator-activated receptor (PPAR) and steroid receptor (PXR), and shows an effect of promoting the transcription of a drug-metabolizing enzyme CYP7A1. The imino compound has a therapeutic effect on diseases such as lifestyle-related diseases, chronic inflammation and cancers.

Abstract: The present invention has an object to develop novel compounds which are effective for the therapy of syndrome X, cancer, myxedema, vascular chronic inflammation and the like, and furthermore prevent/treat the restenosis caused in an artery expansion by a balloon or a stent and have the activity facilitating regenerative medicine by inhibiting rejection of own cells or tissues to be transplanted and the method for preparing the same. Novel acetal derivatives obtained by acylating the hydroxyl group at the 2-position of the orcylaldehyde which ascochlorin and its analogs have and thereafter bonding an alcohol to the aldehyde group in the presence of a basic catalyst are found to achieve the object.

Abstract: A pharmaceutical composition is provided having at least one kind to be selected from the group consisting of a lactoferrin group protein having lactoferrin and conalbumin, and an enzymatically decomposed product of the lactoferrin group protein having peptides corresponding to lactoferricin and lactoferricin of conalbumin as an active ingredient. The composition of the present invention can be used as an agent for improving lipid metabolism. Further, it is useful for treating hypercholesterolemia, hyper-neutral lipidemia, hyper-low density lipoprotein (LDL) cholesterolemia, hypo-high density lipoprotein (HDL) cholesterolemia, obesity, fatty liver and cholesterol gallstone and lifestyle-related diseases such as severe obesity, hyperlipidemia, hypertension and type II diabetes. The composition of the present invention can improve basal metabolic rate.

Abstract: The present invention has an object to develop novel compounds which are effective for the therapy of syndrome X, cancer, myxedema, vascular chronic inflammation and the like, and furthermore prevent/treat the restenosis caused in an artery expansion by a balloon or a stent and have the activity facilitating regenerative medicine by inhibiting rejection of own cells or tissues to be transplanted and the method for preparing the same. Novel acetal derivatives obtained by acylating the hydroxyl group at the 2-position of the orcylaldehyde which ascochlorin and its analogs have and thereafter bonding an alcohol to the aldehyde group in the presence of a basic catalyst are found to achieve the object.

Abstract: Ascochlorin or an analog or derivative thereof and a compound having a primary amino group are mixed and reacted with each other in the presence/absence of a basic catalyst to synthesize a novel imino compound. The novel imino compound thus synthesized is a ligand capable of activating nuclear receptor superfamily such as retinoid orphan receptor (RXR), peroxisome proliferator-activated receptor (PPAR) and steroid receptor (PXR), and shows an effect of promoting the transcription of a drug-metabolizing enzyme CYP7A1. The imino compound has a therapeutic effect on diseases such as lifestyle-related diseases, chronic inflammation and cancers.

Abstract: An imaging device assembly for an electronic stereoscopic endoscope system comprises right and left solid state image pick-up modules set out side by side and right and left circuit boards with circuits formed thereon, respectively, that are connected to the right and left image pick-up modules, respectively. Each circuit board comprises a front section having a width approximately equal to a width of the solid state image pick-up module and a rear section broader than the front board section which is shaped to project laterally so as to overhang a rear section of the other circuit board and on which electronic parts incorporated in the circuit are mounted.

Abstract: A preventive or therapeutic agent for multiple risk factor syndrome containing, as an active ingredient, one or more chemical compounds selected from the group consisting of ascochlorin, ascochlorin homologues, ascofuranone and ascofuranone homologues, each of the chemical compounds having at least an olsyl aldehyde moiety, in which neither of the hydrogen atoms of the 2- and 4-hydroxyl groups are substituted; and the hydrogen atom of at least one of the hydroxyl groups is substituted by a group selected from the group consisting of (C1-C15) alkyl, (C2-C15) alkenyl, (C1-C15) alkylnyl, aryl, (C1-C15) alkylaryl; —(CnH2n)R (where n is an integer of 1 to 15 and R represents COOR? which substitutes for any one of n carbon atoms where R? is H or (C1-C15) alkyl), (C1-C15) alkylcarbonyl, arylcarbonyl, aryl(C1-C15)alkyl, aryl (C1-C15) alkylcarbonyl, —C(?O)(CH2)1-15COOH, 2-pyridylcarbonyl, nicotinoyl, isonicotinoyl, toluenesulfonyl, carbamoyl, carbamoyl substituted by one or two (C1-C6) alkyls, amino, amino substitu

Abstract: The object of this invention is to provide a novel pharmaceutical composition for getting rid of pains and anxiety in patients. This invention relates to a pharmaceutical composition containing lactoferrin as an active ingredient. The composition of this invention is useful for treatment of at least one disease or condition selected from the group consisting of pains, including the phase 1 pain and the phase 2 pain, anxiety and stress. The composition is particularly beneficial to alleviating or getting rid of the pain and anxiety which significantly lower quality of life of patients with end-stage cancer. The composition of this invention is also useful for treatment of pains, including the phase 1 pain and the phase 2 pain, and inflammation which accompany arthritis or diseases in the junctions of bones (e.g. rheumatoid arthritis, osteoarthritis, frozen shoulder, sports injuries such as tennis elbow and baseball shoulder, and low back pain).

Abstract: The present invention provides a pharmaceutical composition having at least one kind to be selected from the group consisting of a lactoferrin group protein comprising lactoferrin and conalbumin, and an enzymatically decomposed product of the lactoferrin group protein comprising peptides corresponding to lactoferricin and lactoferricin of conalbumin an active ingredient. The composition of the present invention can be used as an agent for improving lipid metabolism. Further, it is useful for treating hypercholesterolemia, hyper-neutral lipidemia, hyper-low density lipoprotein (LDL) cholesterolemia, hypo-high density lipoprotein (HDL) cholesterolemia, obesity, fatty liver and cholesterol gallstone and lifestyle-related diseases such as severe obesity, hyperlipidemia, hypertension and type II diabetes. The composition of the present invention can improve basal metabolic rate.